Annexon, Inc. (ANNX) · INSIDERData sourcesSEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago
Public companyAnnexon, Inc.
ANNXCIK 0001528115
Price$4.23
1 year+40.1%
Disclosed transactions7
Buys / sells3 / 1
Max Insider Score36
Connections with evidence6
ANNX · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 36 | LDLove DouglasDirector, PRESIDENT AND CEO | ANNXAnnexon, Inc. Open-market purchase | BUY | $100K 26.1K sh | Sep 24, 2026 | Sep 25, 2026 |
| 9 | CMCockroft Bettina M.Director | ANNXAnnexon, Inc. Grant or award | A | — 65.0K sh | Jun 11, 2026 | Jun 15, 2026 traded Jun 11, 2026 | +4d | SEC Form 4 | |
| 19 | CHCarson William H.Director | ANNXAnnexon, Inc. Open-market purchase · 10b5-1 plan | BUY | $50K 8,000 sh | Apr 10, 2026 | Apr 14, 2026 traded Apr 10, 2026 | +4d | SEC Form 4 | |
| 17 | ARArtis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | ANNXAnnexon, Inc. Grant or award | A | — 62.5K sh | Feb 19, 2026 | Feb 23, 2026 traded Feb 19, 2026 | +4d | SEC Form 4 | |
| 5 | ARArtis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | ANNXAnnexon, Inc. Grant or award | A | — 250.0K sh | Feb 19, 2026 | Feb 23, 2026 traded Feb 19, 2026 | +4d | SEC Form 4 | |
| 21 | ARArtis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | ANNXAnnexon, Inc. Open-market sale | SELL | $27K 5,290 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC Form 4 | |
| 29 | CHCarson William H.Director | ANNXAnnexon, Inc. Open-market purchase · 10b5-1 plan | BUY | $21K 4,115 sh | Dec 30, 2025 | Jan 2, 2026 traded Dec 30, 2025 | +3d | SEC Form 4 | |
EVP & CHIEF SCIENTIFIC OFFICER · Feb 20, 2026
Planned sales and 5% stakes
Form 144, 13D and 13G